ABSTRACT. Numerous epidemiological investigations have evaluated the association between adiponectin gene T45G polymorphism and risk of nonalcoholic fatty liver disease (NAFLD). However, the results of these studies have proven to be inconsistent. Therefore, we conducted a metaanalysis to obtain a more accurate estimation of this association. Published articles were retrieved from PubMed and Web of Science databases and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using fixed-or random-effect models. subjects. In conclusion, the T45G polymorphism of the adiponectin gene may not constitute an NAFLD risk factor. However, this needs to be further validated in single large well-designed future studies.
INTRODUCTION
With the dramatic increase in the prevalence of obesity and metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become a major public health issue worldwide (Ahmed, 2015) . NAFLD includes a spectrum of liver diseases that ranges from simple hepatic steatosis to steatohepatitis, which may subsequently progress to more severe conditions such as cirrhosis or liver cancer (Wong et al., 2011; Della Corte et al., 2012) . The underlying mechanisms responsible for the development and progression of NAFLD are poorly understood. Previous studies have reported that obesity, hypoadiponectinemia, hyperinsulinemia, and diabetes may be causally related to the development of this disease (Shimabukuro et al., 2013) . Moreover, there is currently increasing evidence that genetic factors play important roles in its progression (Romeo et al., 2008) .
Adiponectin is a multifunctional adipocytokine secreted mainly by white adipose tissue, which performs a key function in modulating insulin sensitivity and energy metabolism (BrochuGaudreau et al., 2010) . The 18.5-kb gene encoding adiponectin is located on chromosome 3q27 and consists of three exons. To date, multiple polymorphisms of this gene have been identified (Gable et al., 2006) . One of the most commonly studied of these is the single nucleotide polymorphism T45G, comprising a silent T to G substitution in exon 2. Several studies have demonstrated that this polymorphism can affect plasma adiponectin levels (Li et al., 2007) , and previous meta-analyses have shown that it may contribute to the pathogenesis of polycystic ovary syndrome (Gao et al., 2012) .
A number of recent studies have investigated the association between adiponectin gene T45G polymorphism and NAFLD risk. However, rather than reaching a conclusive consensus, their results are conflicting. Such discrepant findings may be due to small sample sizes, differences in ethnicity, and other limitations in study design (Li et al., 2014) . Therefore, the aim of this investigation was to conduct a meta-analysis of pooled data from existing clinical studies to assess the relationship between adiponectin gene T45G polymorphism and NAFLD.
MATERIAL AND METHODS

Literature search strategy
We conducted an in silico search of the PubMed and Web of Science databases, including articles published up to June 2015, to identify studies focusing on the association between the T45G polymorphism and NAFLD risk using the following search terms: "adiponectin", "polymorphism or polymorphisms", and "nonalcoholic fatty liver disease (NAFLD)". Bibliographies of all of the papers found in this way were then checked for other relevant publications. Furthermore, we performed a manual search of the references included in pertinent articles and reviews.
Inclusion and exclusion criteria
Potentially relevant studies were selected based on the following inclusion criteria: articles had to 1) focus on the association between the adiponectin gene T45G polymorphism and risk of NAFLD; 2) be case-control studies based on unrelated individuals; 3) provide the number of NAFLD cases and controls, and the frequency of the T45G polymorphism; and 4) be published in English. The principal reasons for excluding studies were as follows: 1) articles consisted of a case-only study or overlapping data; 2) sample size was less than 100 individuals; 3) insufficient information was available for data extraction.
Data extraction
Two investigators independently selected the papers and extracted data, and disagreements or uncertainties were resolved by consensus. The following data were obtained: first author's surname, year of publication, country of origin, ethnicity of study population, number of individuals in case and control groups, frequency of adiponectin gene T45G polymorphism in cases and controls, and consistency with Hardy-Weinberg equilibrium (HWE).
Statistical analysis
The strength of the association between the T45G polymorphism and NAFLD risk was evaluated by calculating pooled odds ratios (ORs) with 95% confidence intervals (95%CIs). Pooled ORs were calculated under four comparison models: co-dominant (TT vs GG, TG vs GG, GG vs TT, TG vs TT), dominant (TTGG+TG vs GGTT), and recessive (TTGG vs TG+GGTT). The inconsistency index (I 2 ) was used to estimate heterogeneity among studies, with I 2 > 50% being considered significant. If heterogeneity was found to be present, the random-effect model (the DerSimonian-Laird method) was used to calculate pooled ORs. Otherwise, a fixed-effect model (the Mantel-Haenszel method) was employed (Higgins and Thompson, 2002) . Sensitivity analysis was performed by comparing values generated under the random-effect model to those obtained with the fixed-effect model. Publication bias was determined using a funnel plot and the Begg test (P < 0.05 was considered to represent statistically significant publication bias). Statistical analysis was performed using the Stata 12.0 software (StataCorp., College Station, TX, USA).
RESULTS
Characteristics of the studies included
To ascertain the relationship between NAFLD susceptibility and adiponectin gene T45G polymorphism, articles were retrieved based on the search criteria. The study selection process is shown in Figure 1 . In total, five case-control studies including 597 cases and 701 controls were used in this meta-analysis (Musso et al., 2008; Wang et al., 2008; Tokushige et al., 2009; Zhou et al., 2010; Gupta et al., 2012) . The distribution of genotypes in the control groups was found to be consistent with HWE in all studies (P > 0.05). The main characteristics of the eligible studies are summarized in Table 1 . 
Quantitative synthesis
The combined results concerning the T45G polymorphism and NAFLD risk are summarized in Figure 2 and Table 2 . When all eligible studies were pooled into one dataset for the meta-analysis, we found no statistical association between this polymorphism and NAFLD risk (TT vs GG: OR = 0.83, 95%CI = 0.37-1.86; TG vs GG: OR = 0.76, 95%CI = 0.33-1.79; dominant model: OR = 0.83, 95%CI = 0.37-1.84; recessive model: OR = 1.10, 95%CI = 0.69-1.76). Sensitivity analyses were conducted by altering the statistical models. No discernible effect was noted, indicating that our results were statistically robust. In the stratified analysis by ethnicity, no association between the adiponectin gene T45G polymorphism and NAFLD risk was 
Publication bias
To assess publication bias in the literature used, a Begg's funnel plot was generated and its asymmetry measured (Figure 3) . No publication bias was apparent (all P > 0.05). OR = odds ratio; 95%CI = 95% confidence interval. Table 2 . Summary of odds ratios and 95% confidence intervals relating to the association between the adiponectin gene T45G polymorphism and nonalcoholic fatty liver disease risk.
DISCUSSION
NAFLD is the most common form of chronic liver disease, and may progress to more severe conditions such as cirrhosis or liver cancer. Obesity, insulin resistance, and metabolic syndrome are the major risk factors associated with NAFLD pathophysiology. However, its pathogenesis is incompletely understood. Adiponectin, one of the most abundant cytokines, is secreted by adipose tissue, which regulates glucose and lipid metabolism (Hotta et al., 2000) . Previous studies have demonstrated that a reduction in the systemic level of adiponectin has clinically significant effects and is closely associated with NAFLD (Farrell and Larter, 2006) . Furthermore, prior research has shown that the T45G polymorphism can affect plasma adiponectin concentration (Li et al., 2007) . Several investigations have suggested that this adiponectin sequence variation might be implicated in NAFLD pathogenesis. However, findings contradicting this proposition have also been published. Therefore, we conducted a meta-analysis of all relevant studies to comprehensively evaluate the correlation between adiponectin gene T45G polymorphism and susceptibility to NAFLD. This is the first systematic study of the association between the T45G polymorphism and risk of this disease using a meta-analysis approach. Ultimately, five case-control studies were included and assessed, involving a total of 597 cases and 701 controls. Our results suggested that there was no significant association between the adiponectin T45G polymorphism and NAFLD risk in the overall study population. Because of inter-study environmental and genetic background differences, we performed an ethnicity-specific subgroup analysis, which also showed that this adiponectin polymorphism was not associated with NAFLD risk in Asian subjects. As only one paper involved a Caucasian population, further investigations focusing on Caucasian patients should be taken into consideration in future analysis. Owing to the limited number of eligible studies retrieved for this meta-analysis, caution should be exercised when considering any conclusions drawn.
Meta-analysis is a useful method for overcoming the disadvantages of individual studies by increasing statistical power, but this approach has some limitations. First, between-study heterogeneity in the present study was unsatisfactorily explained, despite the use of subgroup and sensitivity analyses to determine its source. Such heterogeneity might be due to various reasons, including variations in genotyping methods, sample sizes, and other elements of study design. Second, meta-analysis is a retrospective technique that may lead to subject selection bias, and thereby have an effect on the reliability of any results obtained. Third, gene-gene and gene-environment interactions were not tested in the present study, due to the lack of information available in the source articles.
In conclusion, our meta-analysis suggests that adiponectin gene T45G polymorphism is not associated with NAFLD. However, large-scale studies considering gene-gene and geneenvironment interactions should be conducted to further investigate this relationship.
